An innovative Chinese Alzheimer’s drug that hit the domestic market last week, will go through clinical trials on 2,000 patients overseas in 2020.
An innovative Chinese Alzheimer’s drug that hit the domestic market last week, will go through clinical trials on 2,000 patients overseas in 2020.